25 Mar

How Soft DRAM and NAND Prices Could Hurt Micron’s Margins

WRITTEN BY Sneha Nahata

DRAM and NAND pricing decline

Micron (MU) is the largest US manufacturer of DRAM (dynamic random-access memory) and NAND (negative AND) memory chips, which are mainly used in mobile devices and personal computers. However, the company is facing waning demand for memory chips as a result of soft demand in the smartphone as well as the personal computer (or PC) markets. Weak demand for memory chips resulted in higher inventory, which pressured chipmakers to slash the prices of DRAM and NAND memory chips. The US-China trade fears, as well as a slowdown in China (MCHI) (FXI), also dented chip demand.

Japan’s automotive chipmaker Renesas also announced on March 6 that it is stopping chip production at some of its plants in Japan amid a slowdown in demand from China and to combat excess inventory build-up. Chipmakers Advanced Micro Devices (AMD) and NVIDIA (NVDA) are also facing pressure due to an inventory pile-up.

How Soft DRAM and NAND Prices Could Hurt Micron’s Margins

Margins are hurting

Micron’s gross margin contracted 820 basis points YoY to 50.2% in the second quarter of fiscal 2019. The operating margin also significantly declined YoY from 49.4% to 36.2% in the second quarter. Moreover, both gross and operating margin also dropped steeply from the preceding quarter’s margin levels of 59.0% and 49.1%.

Though the company expects the memory chip market to revive soon, the margins recovery might take a little longer given the excessive inventory pile-up.

Latest articles

In Q3, billionaire investor Leon Cooperman's top five holdings were Fiserv, Alphabet, United Continental, Chimera Investment, and Cigna.

In 2018, 3,503 metric tons of gold were produced globally, 1.8% higher than in 2017. Let's look at the world's top gold-producing countries.

TJX Companies (TJX) reported better-than-expected earnings results for the third quarter of fiscal 2020, which ended on November 2.

Despite Canada's legalization of cannabis a year ago, a StatCan survey found that 42% of Canadians have obtained their cannabis from illegal sources.

On November 11, the NHS (National Health Service) approved two cannabis-based medicines, Epidyolex and Sativex, for use in the United Kingdom.

Roku (ROKU) stock tanked more than 5% on Tuesday during market hours. The company said it will issue nearly 1 million common shares today.